SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Gold Price Monitor -- Ignore unavailable to you. Want to Upgrade?


To: Gabriela Neri who wrote (10610)4/25/1998 9:25:00 AM
From: Bobby Yellin  Read Replies (2) | Respond to of 116763
 
what is that?
also curious what is your take on Japanese having such low interest
rates..I thought it was because they were hoping to use their exports
as a way to shore up their economy and it just didn't work..
also heard on CNBC that hedgers are beginning to move into gold..
don't know what abby joseph cohen's latest target is but last I heard
DOW 9300 ..we are almost there
also heard on news show from a wall street journal reporter that Rubin
has no plans of stepping down..(those rumours must have been
from bond traders :>
I really thought that a blow off in biotechs would be the clincher..
The more I think, the more confused I am getting...except I keep on
remembering, in bear markets..stocks can sell way below their value..
also with all the trading going on now..and with reallocations of
portfolios some of the liquidity would have to dry up to pay capital
gains..
also do you agree with ahhha that lower taxes rather than lower interest rates have helped corporation profits more..it just seems that lower interest rates helped their borrowing so much..
(I guess I am still very optimistic about future..ie one company probably just got limited FDA approval for laser heart surgery..
gee how much money will laser technology save in health costs in the
future?..gene therapy etc..technology in exploration of natural resources.,etc....)



To: Gabriela Neri who wrote (10610)4/25/1998 3:07:00 PM
From: paul ross  Respond to of 116763
 
You're erect in your analysis.



To: Gabriela Neri who wrote (10610)4/28/1998 6:26:00 PM
From: goldsnow  Read Replies (2) | Respond to of 116763
 
>>OFF TOPIC >> Viagra

Viagra potency pill is a hit with US women too
04:09 p.m Apr 28, 1998 Eastern
By Maggie Fox, Health and Science Correspondent

WASHINGTON (Reuters) - Praised as a miracle drug for men, Viagra, the
first pill for impotence, is also finding a market among women, doctors
and analysts said Tuesday.

Nearly 150,000 prescriptions have been written for the drug since it
went on the market in the United States this month. Many men with sexual
problems say it has offered them a new lease on life.

But doctors and pharmacists say they are getting plenty of queries from
women as well -- and many are not asking on behalf of their partners.

''A lot of women are interested,'' said Dr. Myron Murdoch, a urologist
in Greenbelt, Maryland, who is national medical director for the
Impotence Institute of America.

''If you think there's a big demand for male sexual dysfunction
medicine, wait until women find out they can have some sort of sexual
dysfunction medicine.''

In commercial terms, Pfizer's drug is already a blockbuster. During its
second week on the market, pharmacists sold more than 113,000 new
prescriptions for Viagra, known generically as sildenafil.

Hemant Shah, an independent drug analyst in New Jersey, said much of the
demand was being driven by women.

''They (pharmacists) are telling me they can't keep it in stock and that
both men and women are using it,'' he said.

Viagra is not approved for women. It was tested only in men and is
designed to act as an ''arousal enhancer,'' getting blood to the penis
to help a man get an erection.

''We get a lot of inquiries as to women. This is absolutely
inappropriate,'' said Dr. James Barada, a urologist in Albany, New York,
who helped draw up erectile dysfunction guidelines for the American
Urological Association (AUA). ''It's so far off-label that it's
pathetic.''

But once a drug is approved, there is little to stop a doctor from
writing an ''off-label'' or unapproved prescription for a woman, though
Viagra's makers stress there is as yet no evidence of any good reason to
do so.

''This is a drug that has been approved for erectile dysfunction, which
is obviously for men, and there is no scientific data to support its use
in women,'' said Pfizer spokeswoman Mariann Caprino.

Pfizer does have Phase II clinical safety tests underway in Europe in a
group of women and some doctors see no reason not to prescribe the drug
to women.

Murdoch said the vagina and clitoris were made of the same tissue as the
penis and a drug that improved blood flow in men would do the same in
women.

''Physiologically ... the clitoris is nothing more than a penis without
a urethra,'' he said. The urethra carries urine and sperm in men.

''The drugs we are using for male sexual dysfunction, these drugs will
be effective in causing increased blood flow in the vagina and in the
clitoris, so that women who have lack of lubrication, we can improve
that.''

Murdoch said doctors could use drugs, including Viagra, to help women
who were worried about losing interest in sex.

''Women who have arousal problems, we can stimulate that. The male
hormone testosterone can improve desire in women.''

That could help relationships in general, he said. ''If you can do all
this, it certainly should lead to an improvement in sexual relationships
between men and women.''

Copyright 1998 Reuters Limited.